---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-294837"
form_type: "8-K"
ticker: "ENTA"
cik: "0001177648"
company_name: "ENANTA PHARMACEUTICALS INC"
filed_at: "2026-07-02T20:56:37+00:00"
generated_at: "2026-07-02T20:58:10.024807+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Enanta enters ATM equity agreement with Jefferies for up to $75M

## Summary
- Open Market Sale Agreement with Jefferies LLC as sales agent for at-the-market offerings.
- Enanta may sell up to $75M of common stock from time to time on Nasdaq.
- Jefferies will receive a commission of up to 3.0% of gross sales price per share.
- Enanta has no obligation to sell any shares under the agreement.
- Prospectus supplement filed July 2, 2026; shelf registration effective February 20, 2026.

## SEC filing metadata
- accession: 0001193125-26-294837
- form_type: 8-K
- ticker: ENTA
- cik: 0001177648
- company_name: ENANTA PHARMACEUTICALS INC
- filed_at: 2026-07-02T20:56:37+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1177648/000119312526294837/0001193125-26-294837-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1177648/000119312526294837/d123412d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-294837
- JSON: https://secwatch.observer/filing/0001193125-26-294837.json
- Plain text: https://secwatch.observer/filing/0001193125-26-294837.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
